导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.53% | 1996/4407 |
| 近一周 | -1.41% | 2273/5016 |
| 近一月 | -4.91% | 1868/4972 |
| 近一季 | -6.99% | 2046/4811 |
| 近半年 | -0.63% | 1597/4547 |
| 近一年 | 2.64% | 1851/4077 |
| 近两年 | 49.81% | 1361/2754 |
| 近三年 | 31.30% | 928/2082 |
| 成立以来 | 70.49% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.97% 2978/4961 |
13.14% 2056/5312 |
- - |
- - |
| 2025 | 20.36% 2128/4813 |
-0.69% 2359/3635 |
1.97% 1981/4076 |
18.02% 2362/4524 |
0.71% 1822/4813 |
| 2024 | 15.59% 908/3463 |
2.52% 760/2808 |
-1.32% 1036/3014 |
15.73% 1643/3129 |
-1.27% 1642/3463 |
| 2023 | -9.49% 1173/2656 |
3.65% 1154/2280 |
-4.63% 1229/2385 |
-2.84% 764/2515 |
-5.76% 1493/2655 |
| 2022 | -17.14% 553/2207 |
-13.56% 786/1919 |
7.37% 488/2016 |
-11.91% 608/2113 |
1.34% 1296/2208 |
| 2021 | 4.52% 572/1822 |
-2.49% 655/1255 |
8.11% 645/1330 |
-2.97% 606/1466 |
2.19% 663/1822 |
| 2020 | 32.03% 491/1250 |
-7.04% 522/1028 |
14.37% 556/1067 |
10.40% 556/1164 |
12.50% 460/1184 |
| 2019 | 34.29% 407/1092 |
24.67% 499/739 |
-0.22% 232/788 |
0.83% 454/850 |
7.07% 490/918 |
| 2018 | - - |
- - |
- - |
0.32% 155/660 |
-11.34% 283/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 招商MSCI中国A股国际ETF联接A VS. 长安沪深300非周期A(740101) |